ABSTRACT
INTRODUCTION
The endoplasmic reticulum (ER) is an intracellular compartment in eukaryotic cells that harbors a wide variety of cellular activities. Nascent polypeptides destined for the secretory pathway are synthesized on membrane bound ribosomes and translocate into the ER where they fold under the supervision of chaperone complexes (reviewed in Pelletier et al. 2001) . The ER quality control process ensures proteins destined for all compartments of the secretory pathway as well as proteins marked for secretion or the cell surface can only leave the ER when they are correctly folded. The ER is also involved in other cellular activities such as lipid biosynthesis, detoxification, calcium storage, calcium signaling and many aspects of cellular stress response. Dysfunction of processes in the ER has been shown to be involved in many human diseases including neurological and aging diseases such as ischemia, epileptic seizures, Alzheimer's, Parkinson's (reviewed in Paschen et al. 2001) as well as cystic fibrosis, cancer and juvenile pulmonary emphysema (Lee, 2001) .
A comprehensive description of the ER requires a catalogue of resident proteins, their interactions, and the pathways in which they are involved. In addition to experimental approaches, informatics provides important tools for defining ER proteins and their functions. Currently however, information regarding ER proteins is dispersed; a small proportion of this data lies in various public and private databases but the majority of the data remains "buried" in research papers in the literature. This makes comprehensive analyses of the ER proteome difficult. We report here the creation of a publicly available database of known and potential human ER proteins and their preliminary analysis via several bioinformatics approaches.
IMPLEMENTATION AND RESULTS

The Hera Database: Structure
The Hera (Human ER Aperçu) database is a publicly available catalogue of known human ER proteins. The entity-relationship model of Hera (shown in Figure 1 ) is implemented in the Open Source relational database MySQL and the database can be queried via the scripting language PHP. The central Accordingly, we have set up a user feedback/contribution interface accessible through the Hera web page. As the Hera Project develops, it is expected that information regarding protein function, post-translational modifications, homology and orthology as well as protein-protein interactions (detected by, for example, on going yeast-two-hybrid experiments) will also be added to the database.
The Hera database: Content
Data relating to human ER proteins was collected from diverse information sources by entering the keywords 'ER' and 'endoplasmic reticulum'. Each entry was then manually screened to verify the localization evidence and to determine the classification criteria of the entry. When the information source was the scientific literature, each article was read to evaluate the evidence presented.
These data sources and their associated criteria or type of evidence for the localization of these proteins to the ER are shown in table 1. This information is important since the proteins present in Hera have been annotated as ER proteins according to vastly different criteria, and these methods vary in stringency and levels of quality control. This collection process produced over 1000 ER proteins.
Many of these proteins were present more than once under different names and accession numbers. Duplicated sequences were removed before entry into the database using a specially designed sequence alignment program developed in our lab. The program implements the Smith-Waterman algorithm for pairwise alignment with affine gap costs in a linear space (Smith and Waterman, 1981) . To score the alignment, we use the BLOSUM62 score matrix, and a gap cost of -8 per unaligned residue. The probability of score is calculated based on the methods of Altschul and Gish, 1996 . The program performs pairwise alignment of amino acid sequences and estimates the score of similarity and its probability, which are then used for human curation of the entries. Sequences identical to other entries were removed from the database.
Many classification sources label proteins as belonging to the ER even though they are only anchored on the cytoplasmic side of the ER or found in the ER periphery. By manually searching the scientific literature, our last curation step identified several such proteins in our database and relabelled them as belonging to a special class called "ER periphery". After curation, the database contained 499 human ER proteins.
Of the 499 ER proteins, 343 are classified as ER proteins based on experimental evidence (classification label 'e') or because the information source that provided this localization annotated the protein as being localized in the ER with a high degree of certainty (classification label 'c'). We refer to this set as the kernel ER proteins. This set of proteins does not include any ER proteins from the literature or public databases where authors employ categorizations such as "potential ER protein". Furthermore, proteins localized to the ER only via homology or by similarity search were not included in the kernel group. Our rationale for not allowing such localizations is based on several cases where such similarity searches predict human proteins to be classified as ER, whereas other sources predict these proteins to be non-ER. Such false predictions tend to occur when the protein is similar to an ER protein in another species. (However, whenever possible, we confirmed the ER localization of all these proteins by
Characteristics of ER proteins
We used the Hera database to identify characteristics shared by all ER proteins or subgroups of ER proteins.
Physical properties
The molecular weight and isoelectric point ( Signal peptides and entry into the secretory pathway Amino-terminal signal peptides are frequently responsible for targeting of nascent polypeptides to the ER allowing for subsequent transport through the secretory pathway (Rapoport, 1992 , von Heijne, 1990 . As polypeptide synthesis progresses, the amino-terminal signal peptide is recognized by the signal recognition particle (SRP) which causes the ribosome to come into contact with the ER and allows for the insertion of the nascent peptide chain into the ER.
SignalP is a publicly available high accuracy tool that predicts the presence of signal peptides and anchors in proteins (Nielsen et al., 1997) . We submitted the sequences of all the proteins in our database to SignalP (version 2.0). We also submitted sequences from 1756 human non-ER proteins with subcellular localization annotation in GeneCards (Safran et al., 2002) . Figure 3A shows that 70% of the 343 kernel ER proteins contain either a signal peptide or a signal anchor. As well, our analysis also indicates that 80% of soluble kernel ER proteins contain a signal peptide (not shown in Figure 3A ). Other organelles of the secretory pathway also display a low percentage of proteins containing such signals: only 59% of all the proteins whose localization is the Golgi apparatus in GeneCards contain a signal peptide or anchor. By manually examining the Hera database, we have noticed that some proteins classified as ER in public databases or the published literature are simply bound to the cytoplasmic side of these organelles and thus do not require entry into the secretory pathway. We have relabeled these proteins as located at the ER periphery in Hera, and thus they are not part of the present analysis (and are not part of the set of kernel ER proteins). It is possible that a small number of such proteins are still labeled as ER in Hera. We note however that they would certainly not account for the 30% of kernel ER proteins that contain neither signal peptides nor anchors. It is equally unlikely that this high percentage of ER proteins carrying neither signal peptides nor anchors be due to other types of classification error in the Hera, SwissProt or GeneCards databases or prediction error due to SignalP. In contrast, a higher proportion of plasma membrane proteins and secreted proteins contain a signal peptide or anchor; these two localizations are more representative of what is expected for proteins of all compartments of the secretory pathway (Rapoport, 1992) . As anticipated, a much smaller proportion of proteins in organelles that are not part of the secretory pathway contain a signal peptide or anchor.
Since a high proportion of proteins of the secretory pathway contain neither a signal peptide nor an anchor, it can be asked whether other insertion mechanisms into the ER are used in human cells. It is well known that S. cerevisiae is capable of post-translational translocation of large precursors in an SRP-independent manner (Ng et al., 1996; Zheng and Gierasch, 1996) . It has been shown that unlike mammalian systems, yeast cells depleted of SRP are viable (Kalies and Hartmann, 1998) . However, SRP independent posttranslational protein translocation across the ER membrane does occur in higher eukaryotes in the case of small proteins of fewer than 75 amino acids in length (Muller and Zimmermann, 1987; Kalies and Hartmann, 1998) . Additionally, it has been shown that many tail-anchored proteins have the capacity for posttranslational insertion into the ER (Kutay et al., 1995; Linstedt et al., 1995; Behrens et al., 1996) . Tail-anchored proteins are characterized by their lack of a signal peptide or anchor and the presence of a single carboxy-terminal transmembrane domain that acts as a membrane insertion sequence (Abell et al., 2003) . A recent study provides evidence that tail-anchored proteins and signal-anchored proteins use membrane insertion pathways that share common elements (Abell et al., 2003) . By searching the Hera database, we identified 17 such tail-anchored kernel ER proteins (8.4% of kernel ER membrane proteins).
We have further analyzed the remaining 86 kernel ER proteins which contain neither a signal peptide nor a signal anchor as predicted by SignalP and which are not tail-anchored proteins. Fifty-eight of these proteins are insoluble and 45 of these contain at least 3 transmembrane domains. Such polytopic proteins probably possess ER membrane insertion sequences in their membrane spanning regions. It has recently been show that different transmembrane domains of a polytopic protein interact with different element of the ER translation machinery (Meacock et al., 2002) . Some polytopic proteins have been shown to be inserted both co and post-translantionally in microsomal membranes (Kanner et al., 2002) . Finally, there are 28 soluble ER resident proteins that do not contain a signal peptide as predicted by SignalP. These include well-known ER lumenal proteins such as DPM1 (Maeda et al., 2000) . By using pattern recognition programs such as teireisias (Rigoutsos and Floratos, 1998) , we have searched for subsequences common to several of these proteins that might serve as ER targeting signals, but have found none. Further analysis of these proteins will be required. The classification of the kernel ER proteins depending on their solubility and signal types is shown in Figure 3B .
Transmembrane domains
It has been estimated that in most organisms, including Homo sapiens, between 20 and 35% of all cellular proteins contain at least one transmembrane domain (Stevens and Arkin, 2000) . We analyzed the kernel ER proteins using TMHMM (Krogh et al., 2001) . TMHMM has been shown to generally outperform other publicly available transmembrane domain predictors in a comparative study (Möller et al., 2001) . Table 2 shows the distribution of transmembrane domains in ER proteins in the database. Twenty-four of the kernel ER proteins contain more than 7 transmembrane domains. These proteins include enzymes involved in protein glycosylation and modification of sugar chains, calcium channels, other types of transporters and proteins involved in lipid biosynthesis. Most ER proteins, however, contain fewer than 8 transmembrane domains.
Retention/retrieval signals
The carboxy-terminal KDEL signal is the most well known ER retrieval sequence. Since its discovery (Munro and Pelham, 1987) , it has been found to be widely used in many different organisms and has been extended to the much more general Prosite consensus pattern [KRHQSA]-[DENQ]-E-L> (Sigrist CJ et al., 2002) . We have searched Hera for proteins containing this signal, using a program we developed in our lab. In total, 18.4% of the soluble proteins in the kernel ER set have the Prosite KDEL-like sequence. If we extend the pattern to Table 3 shows the most prevalent carboxy-terminal KDEL-like motifs in kernel ER proteins. Among the remaining 73.8% of soluble kernel ER proteins that do not contain this signal, 9 proteins contain carboxy-terminal sequences somewhat similar to the extended KDEL motif. These sequences are QEDL>, necessary to experimentally verify the functionality of these possible retrieval signals.
Other well-characterized ER sorting signals include the carboxy-terminal di-lysine motif, which has been shown to be necessary and sufficient for ER retention for some proteins, and the amino-terminal di-arginine motif (reviewed in Teasdale and Jackson, 1996) . These motifs are believed to be used by type I and type II membrane proteins respectively. We analyzed the 202 membrane proteins in the kernel ER set for the presence of these motifs. The di-lysine motif was generalized to the pattern UUUXX> where at least 2 out of the 3 U's must be a lysine, X can be any amino acid and > indicates the carboxy-terminal end of the protein. Although this motif is not believed to be widely used (Teasdale and Jackson, 1996) , our results indicate that 22.8% of ER membrane proteins contain this carboxy-terminal motif. If we extend the motif to UUUUX> where at least 2 out the 4 U's must be a basic residue (lysine, arginine or histidine), we obtain that 38.6% of ER membrane proteins contain this motif. It will be necessary to experimentally assess the biological relevance of this extended motif. Table 4 shows the most common carboxy-terminal basic tetrapeptides present in human ER proteins. Our results do not agree well with previous values obtained by a combinatorial screen in mammalian cells to determine the carboxy-terminal tetrapeptides that are most efficient in retaining proteins in the ER (Zerangue et al., 2001) , suggesting that other parts of the protein sequence also play an important part in determining the final localization of the protein.
line with the belief that the motif is more widely used by Golgi proteins than ER proteins. In total, 36.2% of the 343 kernel ER set of proteins contain the KDELlike, the di-lysine or the di-arginine retention motifs.
Other ER retention motifs have been described, including the internal RXR motif for membrane proteins (Shikano et al., 2003) and the cytochrome b5 transmembrane domain (Honsho et al., 1998) . However, most of these motifs are either too general (i.e. equal proportions of ER and non-ER proteins contain these motifs and these motifs might be position-specific) or too specific (i.e.
found in very few ER proteins, possibly only one) to be used in the analysis of the kernel ER set. In the case of soluble ER proteins, a KDEL-receptor independent ER retention has been described for the lysyl hydroxylase protein (Suokas et al., 2003) . Other retention mechanisms have been proposed including retention by oligomerization and through membrane thickness (reviewed in Nilsson and Warren, 1994) .
Protein domains and motifs
We assessed the presence of different protein motifs and domains in ER proteins via InterProScan software (Mulder et al., 2003) . This software provides a platform for an integrated use of many secondary protein databases. We also used this software to scan 1756 proteins annotated in GeneCards as being in compartments other than the ER. In total, 84.5% of the 343 kernel ER proteins contain at least one domain or motif corresponding to an InterPro entry. Table 5 shows the most abundant InterPro entries found in ER proteins. The InterPro entry recognized in the largest number of ER proteins is the cytochrome P450 motif, which is present in 10.8% of the ER proteins. Cytochrome P450 proteins are involved in the metabolism of many different compounds by acting as terminal oxidases in electron transfer chains. Most eukaryotic cytochrome P450s are believed to be localized at microsomal membranes (Werck-Reichhart and Feyereisen, 2000) . Three children motifs (motifs that further characterize a subgroup of proteins that contain the parent motif) of the InterPro cytochrome P450 motif were detected in ER proteins (not shown in table 5). These are the Eclass P450 group I, E-class P450 group II and E-class P450 group IV motifs.
The second most abundant motif in ER proteins (Table 5) is the UDPglucosyl transferase motif, which is used by proteins involved in the folding and quality control pathway of the ER (Ellgaard and Helenius, 2003) . This motif seems specific to ER proteins since none of the 1756 non-ER proteins contain it.
The thioredoxin domain 2 motif is also present in several chaperone-like ER proteins. Thioredoxins are small protein disulphide oxidoreductases (Martin, 1995) . Other motifs that appear to be ER-specific are related to calcium storage and regulation, transport and signaling pathways; these are all well studied functions of the ER. In contrast, the protein kinase motif is contained indiscriminately in ER and non-ER proteins, indicating that it is not ER-specific.
The calcium-binding EF-hand, the thioredoxin domain 2 and the esterase/lipase/thioesterase families are present in proteins in several different compartments indicating that different organelles share some similar functions.
Most of the abundant motifs in ER proteins detected by InterProScan seem to be present in proteins involved in the well-characterized functions of the ER. The study of ER-specific motifs is important in the characterization of the ER and the determination of its detailed role in the cell.
Future improvements
The Hera database was built to store characteristics of human ER proteins. As the Hera project progresses, we will add new features to the database including information regarding protein isoforms, other names (synonyms), interaction partners and mechanisms of involvement in human disease where relevant. As well, we are in the process of adding yeast ER proteins to Hera and we will subsequently include ER proteins from other species. This will allow us to better address the question of the completeness of the database and will provide a platform for evolutionary studies of ER proteins and pathways. We will also further annotate the Hera database to provide functional classification of the proteins and integrate experimental protein interaction data. Hera is a unique resource that will allow a comprehensive characterization of ER proteins and thus improve our understanding of this organelle and its associated diseases. We believe the Hera database will help biologists in increasing the efficiency of finding useful and relevant information regarding ER proteins, as well as bioinformaticians in the characterization of the human proteome. 
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Types of classification labels a NCBI, Genbank k,t,c,h SwissProt (Boeckmann et al., 2003) c,s,p PubMed and scientific literature e GeneCards v2.26 (Safran et al., 2002) The other tables contain incomplete information. 
